Cargando…
Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model
OBJECTIVES: STM-001, a retargeted glycopeptide, is active against MDR E. coli expressing ESBLs including carbapenemases. Herein, we assessed its capability to combat E. coli complicated urinary tract infections (cUTI) in mice driven by clinically important serine (CTX-M-15) and metallo-β-lactamases...
Autores principales: | Neville, Lewis F., Shalit, Itamar, Warn, Peter A., Rendell, Jacob T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155633/ https://www.ncbi.nlm.nih.gov/pubmed/35229156 http://dx.doi.org/10.1093/jac/dkac063 |
Ejemplares similares
-
In Vivo Targeting of Escherichia coli with Vancomycin-Arginine
por: Neville, Lewis F., et al.
Publicado: (2021) -
STM tip-assisted engineering of molecular nanostructures: PTCDA islands on Ge(001):H surfaces
por: Ahmad Zebari, Amir A, et al.
Publicado: (2013) -
Atomic structures of self-assembled epitaxially grown GdSi(2) nanowires on Si(001) by STM
por: Song, Sun Kyu, et al.
Publicado: (2019) -
1508. Carbapenem vs. Non-carbapenem as Empiric Regimens for Bacteremia Caused by ESBL Producing Escherichia coli and Klebsiella pneumoniae in Children: Preliminary Study
por: Park, Saera, et al.
Publicado: (2019) -
Carbapenem-Sparing Strategies for ESBL Producers: When and How
por: Karaiskos, Ilias, et al.
Publicado: (2020)